A Review of Cleanroom Microflora: Types, Trends, and Patterns

References

1. 1.↵
   1. Akers J. E.

   Environmental monitoring and control: proposed standards, current practices, and future directions. J. Pharm. Sci. Technol. 1997, 51 (1), 36–47.

   OpenUrl
2. 2.↵
   USP—National Formulary. Chapter 〈1116〉. Microbiological Evaluation of Clean Rooms; 34th ed.; U.S. Pharmacopeial Convention: Rockville, MD, 2011.
3. 3.↵
   Food and Drug Administration (FDA). Guideline on Sterile Drug Products Produced by Aseptic Processing. FDA: Rockville, MD, 2004.
4. 4.↵
   Euradlex. The Rules Governing Medicinal Products in the European Community, Annex 1; European Commission: Brussels, 2009.
5. 5.↵
   1. Gao Z.,
   2. Tseng C. H.,
   3. Pei Z.,
   4. Blaser M. J.

   Molecular analysis of human forearm superficial skin bacterial biota. Proc. Nat. Acad. Sci. USA 2007, 104 (8), 2927–2932.

   OpenUrlAbstract/FREE Full Text
6. 6.↵
   1. Costello E. K.,
   2. Lauber C. L.,
   3. Hamady M.,
   4. Fierer N.,
   5. Gordon J. I.,
   6. Knight R.

   Bacterial community variation in human body habitats across space and time. Science 2009, 326, 1694–1697.

   OpenUrlAbstract/FREE Full Text
7. 7.↵
   1. Grice E. A.,
   2. Kong H. H.,
   3. Renaud G.,
   4. Young A. C.,
   5. Bouffard G. G.,
   6. Blakesley R. W.,
   7. Wolfsberg T. G.,
   8. Turner M. L.,
   9. Segre J. A.

   A diversity profile of the human skin microbiota. Genome Research 2008, 18 (7), 1043–1050.

   OpenUrlAbstract/FREE Full Text
8. 8.↵
   1. Grice E. A.,
   2. Kong H. H.,
   3. Conlan S.,
   4. Deming C. B.,
   5. Davis J.,
   6. Young A. C.,
   7. Bouffard G. G.,
   8. Blakesley R. W.,
   9. Murray P. R.,
   10. Green E. D.,
   11. Turner M. L.,
   12. Segre J. A.

   Topographical and temporal diversity of the human skin microbiome. Science 2009, 324 (5931), 1190–1192.

   OpenUrlAbstract/FREE Full Text
9. 9.↵
   1. Moissl C.,
   2. Osma S.,
   3. La Duc M. T.,
   4. Dekas A.,
   5. Brodie E.,
   6. DeSantis T.,
   7. Venkateswaran K.

   Molecular bacterial community analysis of cleanrooms where spacecraft are assembled. FEMS Micrbiol. Ecol. 2007, 61 (3), 509–521.

   OpenUrl
10. 10.↵
    1. Owers K. L.,
    2. James E.,
    3. Bannister G. C.

    Source of bacterial shedding in laminar flow theatres. J. Hosp. Infect. 2004, 58 (3), 230–232.

    OpenUrlCrossRefPubMed
11. 11.↵
    1. La Duc M. T.,
    2. Osman S.,
    3. Vaishampayan P.,
    4. Piceno Y.,
    5. Andersen G.,
    6. Spry J. A.,
    7. Venkateswaran K.

    Comprehensive census of bacteria in clean rooms by using DNA microarray and cloning methods. Appl. Environ. Microbiol. 2009, 75 (20), 6559–6567.

    OpenUrlAbstract/FREE Full Text
12. 12.↵
    1. Halls N.

    1. Halls N.

    Effects and Causes of Contamination Control in Sterile Manufacturing. In Microbiological Contamination Control in Pharmaceutical Cleanrooms; Halls N. Ed.; CRC Press: Boca Raton, FL, 2004; pp 8–12.
13. 13.↵
    1. Ackers J.,
    2. Carleton F.

    1. Haberer K.

    Cleaning and Disinfection in the Control of Pharmaceutical Cleanrooms. In Validation of Pharmaceutical Processes, 3rd ed.; Ackers J., Carleton F. Eds.; Informa Healthcare: New York, 2008; pp 303–337.
14. 14.↵
    1. Jiminez L.

    1. Jiminez L.

    Microorganisms in the Environment and their relevance to Pharmaceutical Processes. In Microbial Contamination Control in the Pharmaceutical Industry; Jiminez L. Ed.; Marcel Dekker: New York, 2004; pp 8–9.
15. 15.↵
    1. Whyte W.

    Cleanroom Technology: Fundamentals of Design, Testing, and Operation; John Wiley and Sons: London, 2001; pp 243–246.
16. 16.↵
    1. Clarridge J.

    Impact of 16S rRNA gene sequence analysis for identification of bacteria on clinical microbiology and infectious diseases. Clin. Microbiol. Rev. 2004, 17, 840–862.

    OpenUrlAbstract/FREE Full Text
17. 17.↵
    1. Wu G. F.,
    2. Liu X. H.

    Characterization of predominant bacteria isolates from clean rooms in a pharmaceutical production unit. J. Zhejiang Univ. Sci. B 2007, 8 (9), 666–672.

    OpenUrlCrossRefPubMed
18. 18.↵
    1. Favero M.,
    2. Puleo J.,
    3. Marshall J.,
    4. Oxborrow G.

    Comparative levels and types of microbial contamination detected in industrial cleanrooms. Appl. Microbiol. 1966, 14 (4), 539–551.

    OpenUrlPubMed
19. 19.↵
    1. Favero M. S.,
    2. Puleo J. R.,
    3. Marshall J. H.,
    4. Oxborrow G. S.

    Comparison of microbial contamination levels among hospital operating rooms and industrial clean rooms. Appl. Microbiol. 1968, 16 (3), 480–486.

    OpenUrlPubMed
20. 20.↵
    1. Hyde W.

    Origin of bacteria in the cleanroom and their growth requirements. PDA J. Pharm. Sci. Technol. 1998, 52 (4), 154–158.

    OpenUrlFREE Full Text
21. 21.↵
    1. Hodges N.,
    2. Hanlon G.

    1. Johnson S.

    Microbiological Environmental Monitoring. In Industrial Pharmaceutical Microbiology: Standards and Controls; Hodges N., Hanlon G. Eds.; Euromed Communications: Basingstoke, UK, 2003.
22. 22.↵
    1. Heikens E.,
    2. Fleer A.,
    3. Paauw A.,
    4. Florijn A.,
    5. Fluit A. C.

    Comparison of genotypic and phenotypic methods for species-level identification of clinical isolates of coagulase-negative Staphylococci. J. Clin. Microbiol. 2005, 43 (5), 2286–2290.

    OpenUrlAbstract/FREE Full Text
23. 23.↵
    1. La Duc M. T.,
    2. Dekas A.,
    3. Osman S.,
    4. Moissl M.,
    5. Newcombe D.,
    6. Venkateswaran K.

    Isolation and characterization of bacteria capable of tolerating the extreme conditions of cleanroom environments. Appl. Environ. Microbiol. 2007, 73 (8), 2600–2611.

    OpenUrlAbstract/FREE Full Text
24. 24.↵
    1. Bartnett C.,
    2. Polarine J.,
    3. Lopolito P.

    Control strategies for fungal contamination in cleanrooms. Controlled Environments 2007, http://www.cemag.us/article/control-strategies-fungal-contamination-cleanrooms
25. 25.↵
    1. Ramstorp M.,
    2. Gustavsson M.,
    3. Gudmundsson A.

    Particle generation from humans—a method of experimental studies in cleanroom technology. In Indoor Air 2005: Proceedings of the 10th International Conference on Indoor Air Quality and Climate; Tsinghua University Press, 2005; Vol. 1–5, pp 1572–1576.
26. 26.↵
    1. Hall G. S.,
    2. Mackintosh C. A.,
    3. Hoffman P. N.

    The dispersal of bacteria and skin scales from the body after showering and after application of a skin lotion. Journal of Hygiene 1986, 97 (2), 289–298.

    OpenUrlPubMed
27. 27.↵
    1. Ramstorp M.

    Introduction to Contamination Control and Cleanroom Technology; Wiley-VCH: Weinheim, Germany, 2000.
28. 28.↵
    1. Whyte W.,
    2. Bailey P. V.

    Reduction of microbial dispersion by clothing. J. Parenter. Sci. Technol. 1985, 39 (1), 51–61.

    OpenUrlPubMed
29. 29.↵
    1. Forbes B. A.,
    2. Sahm D. F.,
    3. Weissfeld A. F.

    Bailey and Scott's Diagnostic Microbiology; Mosby Press: St. Louis, MO, 1998.
30. 30.↵
    1. Sutton S. V. W.,
    2. Cundell A. M.

    Microbial identification in the pharmaceutical industry. Pharmacopeial Forum 2004, 30 (5), 1884–1894.

    OpenUrl
31. 31.↵
    1. Petti C. A.,
    2. Polage C. R.,
    3. Schreckenberger P.

    The role of 16S rRNAgene sequencing in identification of microorganisms misidentified by conventional methods. J. Clin. Microbiol. 2005, 43 (12), 6123–6125.

    OpenUrlAbstract/FREE Full Text
32. 32.↵
    1. Maxam A. M.,
    2. Gilbert W.

    A new method for sequencing DNA. Proc. Nat. Acad. Sci. 1977, 74, 560–564.

    OpenUrlAbstract/FREE Full Text
33. 33.↵
    1. Tang Y. W.,
    2. Ellis N. M.,
    3. Hopkins M. K.,
    4. Smith D. H.,
    5. Dodge D. E.,
    6. Persing D. H.

    Comparison of phenotypic and genotypic techniques for identification of unusual aerobic pathogenic Gram-negative bacilli. J. Clin. Microbiol. 1998, 36 (12), 3674–3679.

    OpenUrlAbstract/FREE Full Text
34. 34.↵
    1. Garrity M. G.

    Bergey's Manual of Systematic Bacteriology; Garrity M. G. Ed.; Williams and Wilkins: London, 2005.
35. 35.↵
    Parenteral Drug Association Technical Report 13. Revised fundamentals of an environmental monitoring program. J. Pharm. Sci. Technol. 2001, 55, 33.

    OpenUrl
36. 36.↵
    1. Nagarkar P. P.,
    2. Ravetkar S. D.,
    3. Watve M. G.

    Oligophilic bacteria as tools to monitor aseptic pharmaceutical production units. Appl. Environ. Microbiol. 2001, 67 (3), 1371–1374.

    OpenUrlAbstract/FREE Full Text
37. 37.↵
    1. Kell D. B.,
    2. Kaprelyants A. S.,
    3. Weichert D. H.,
    4. Harwood C. R.,
    5. Barer M. R.

    Viability and activity in readily culturable bacteria: a review and discussion of the practical issues. Antonie van Leeuwenhoek 1998, 73 (2), 169–187.

    OpenUrlCrossRefPubMedWeb of Science
38. 38.↵
    1. Oliver J. D.

    Recent findings on the viable but nonculturable state in pathogenic bacteria. FEMS Microbiol. Rev. 2010, 34 (4), 415–425.

    OpenUrlAbstract/FREE Full Text
39. 39.↵
    1. Cobo F.,
    2. Concha Á.

    Environmental microbial contamination in a stem cell bank. Lett. Appl. Microbiol. 2007, 44 (4), 379–386.

    OpenUrlPubMed
40. 40.↵
    1. Bitkover C. Y.,
    2. Marcusson E.,
    3. Ransjo U.

    Speed of coagulase-negative Staphylococci during cardiac operations in a modern operating room. Ann. Thorac. Surg. 2000, 69, 1110–1115.

    OpenUrlCrossRefPubMedWeb of Science
41. 41.↵
    1. Booth C.

    Microbe monitoring. Cleanroom Technology 2006, 18–20.
42. 42.↵
    1. Cundell A. M.

    Microbial testing in support of aseptic processing. Pharmaceutical Technology 2004, June, 56–66.